IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $833,038 | -7.2% | 99,765 | +2.5% | 0.00% | – |
| Q2 2023 | $898,014 | -30.3% | 97,293 | +3.7% | 0.00% | – |
| Q1 2023 | $1,289,032 | +6.2% | 93,816 | +31.5% | 0.00% | – |
| Q4 2022 | $1,213,595 | -23.9% | 71,346 | +1.8% | 0.00% | -100.0% |
| Q3 2022 | $1,594,000 | +35.3% | 70,096 | +7.4% | 0.00% | – |
| Q2 2022 | $1,178,000 | -57.1% | 65,285 | -36.4% | 0.00% | -100.0% |
| Q1 2022 | $2,744,000 | +63.7% | 102,623 | +79.7% | 0.00% | – |
| Q4 2021 | $1,676,000 | -54.4% | 57,121 | +2.2% | 0.00% | -100.0% |
| Q3 2021 | $3,674,000 | -13.2% | 55,867 | +9.8% | 0.00% | 0.0% |
| Q2 2021 | $4,234,000 | +12.6% | 50,881 | +3.8% | 0.00% | 0.0% |
| Q1 2021 | $3,761,000 | -6.1% | 49,033 | +8.1% | 0.00% | -50.0% |
| Q4 2020 | $4,007,000 | +18.2% | 45,379 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $3,390,000 | -32.2% | 45,917 | -33.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000,000 | +49.7% | 68,488 | +15.1% | 0.00% | 0.0% |
| Q1 2020 | $3,341,000 | +49.8% | 59,490 | +1.8% | 0.00% | +100.0% |
| Q4 2019 | $2,231,000 | – | 58,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |